Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Wieseler

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|June 22, 2011
Still waiting for functional EU Clinical Trials RegisterBeate Wieseler, Natalie McGauran, Thomas Kaiser
Journal of the American Geriatrics Society|October 8, 2009
If shrimps had lips, they could whistle Julia Kreis, Thomas Kaiser, Beate Wieseler
Journal of Clinical Epidemiology|April 8, 2026
When prices soar, progress stalls: How high drug costs hinder meaningful and ethical medical researchPhilip Kranz, Natalie McGauran, Beate Wieseler
BMJ (Clinical Research Ed.)|July 12, 2019
New drugs: where did we go wrong and what can we do better?Beate Wieseler, Natalie McGauran, Thomas Kaiser
BMJ (Clinical Research Ed.)|November 28, 2012
We need access to data on all clinical trials, not just someBeate Wieseler, Natalie McGauran, Thomas Kaiser
JAMA Internal Medicine|November 4, 2014
New EMA policy-further measures needed to support comparative effectiveness assessmentsBeate Wieseler, Natalie McGauran, Thomas Kaiser
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|August 13, 2010
[False self-possession]Monika Lelgemann, Beate Wieseler, Antes Gerd
The Lancet Regional Health. Europe|January 1, 2026
Generating evidence that meets the requirements of both regulatory agencies and HTA bodiesBeate Wieseler, Daniela Preukschat, Philip Kranz
Health Policy (Amsterdam, Netherlands)|December 3, 2014
Response to letter to the editor on "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116(2-3) (2014) 147-153]Helmut Hörn, Katrin Nink, Natalie McGauran, et al.
Deutsches Arzteblatt International|November 29, 2012
Early assessment of benefitsThomas Kaiser, Stefan Lange, Beate Wieseler, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|June 22, 2011
Still waiting for functional EU Clinical Trials RegisterBeate Wieseler, Natalie McGauran, Thomas Kaiser
Journal of the American Geriatrics Society|October 8, 2009
If shrimps had lips, they could whistle Julia Kreis, Thomas Kaiser, Beate Wieseler
Journal of Clinical Epidemiology|April 8, 2026
When prices soar, progress stalls: How high drug costs hinder meaningful and ethical medical researchPhilip Kranz, Natalie McGauran, Beate Wieseler
BMJ (Clinical Research Ed.)|July 12, 2019
New drugs: where did we go wrong and what can we do better?Beate Wieseler, Natalie McGauran, Thomas Kaiser
BMJ (Clinical Research Ed.)|November 28, 2012
We need access to data on all clinical trials, not just someBeate Wieseler, Natalie McGauran, Thomas Kaiser
JAMA Internal Medicine|November 4, 2014
New EMA policy-further measures needed to support comparative effectiveness assessmentsBeate Wieseler, Natalie McGauran, Thomas Kaiser
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|August 13, 2010
[False self-possession]Monika Lelgemann, Beate Wieseler, Antes Gerd
The Lancet Regional Health. Europe|January 1, 2026
Generating evidence that meets the requirements of both regulatory agencies and HTA bodiesBeate Wieseler, Daniela Preukschat, Philip Kranz
Health Policy (Amsterdam, Netherlands)|December 3, 2014
Response to letter to the editor on "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116(2-3) (2014) 147-153]Helmut Hörn, Katrin Nink, Natalie McGauran, et al.
Deutsches Arzteblatt International|November 29, 2012
Early assessment of benefitsThomas Kaiser, Stefan Lange, Beate Wieseler, et al.
Pageof 5